Factors connected with the female sex seem to play an important role in differentiated thyroid cancer

被引:19
|
作者
Przybylik-Mazurek, Elwira [1 ]
Hubalewska-Dydejczyk, Alicja [1 ]
Fedorowicz, Anna [1 ]
Pach, Dorota [1 ]
机构
[1] Jagiellonian Univ, Coll Med, Chair & Dept Endocrinol, PL-31501 Krakow, Poland
关键词
Thyroid cancer; estrogens; progesterone; pregnancy; miscarriage; HORMONAL FACTORS; POOLED ANALYSIS; RISK-FACTORS; ESTROGEN; PREGNANCY; WOMEN; EXPRESSION; HISTORY; NODULES; GROWTH;
D O I
10.3109/09513590.2011.563909
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. The aim of the study was to analyze whether female sex hormones and other factors connected with the female sex could increase the risk of differentiated thyroid cancer (DTC). Material and methods. Ninety-nine patients with a mean age +/- SD of 40.5 +/- 5.9 years with DTC and 51 healthy women with a mean age of 36.52 +/- 8.3 years were examined. Gynecological and obstetric histories were taken and serum estradiol and progesterone levels were analyzed in all women. Results. Patients with DTC had more frequent menstrual cycle disturbances, used hormone-containing medicines more frequently, were mulitiparous more frequently, had spontaneous miscarriages more frequently, and their duration of lactation was significantly shorter than in controls. The mean serum estradiol level +/- SD in women with DTC was significantly higher than in the controls, in the follicular phase 193.74 +/- 66.31 vs. 157.63 +/- 42.88 pmol/l and in the luteal phase 519 +/- 176.9 vs. 369 +/- 71.49 pmol/l. The mean serum progesterone level +/- SD was higher in the controls than in patients with DTC, in the follicular phase: 2.11 +/- 0.70 vs. 1.38 +/- 0.56 nmol/l and in the luteal phase 20.95 +/- 17.46 vs. 17.31 +/- 12.28 nmol/l. Conclusions. The results of these studies imply that estrogens may at least modify the proliferation of thyroid cancer cells. The sex hormones probably intensify the actions of other carcinogens as well.
引用
收藏
页码:150 / 155
页数:6
相关论文
共 50 条
  • [21] The role of surgery in the current management of differentiated thyroid cancer
    Conzo, Giovanni
    Avenia, Nicola
    Bellastella, Giuseppe
    Candela, Giancarlo
    de Bellis, Annamaria
    Esposito, Katherine
    Pasquali, Daniela
    Polistena, Andrea
    Santini, Luigi
    Sinisi, Antonio Agostino
    ENDOCRINE, 2014, 47 (02) : 380 - 388
  • [22] Differentiated Thyroid Cancer: The Role ofATANodal Risk Factors in N1b Patients
    Taboni, Stefano
    Paderno, Alberto
    Giordano, Davide
    Albano, Domenico
    Piana, Simonetta
    Zanetti, Eleonora
    Bertagna, Francesco
    Grammatica, Alberto
    Ghidini, Angelo
    Cappelli, Carlo
    Bozzola, Anna
    Baronchelli, Carla
    Nicolai, Piero
    Lombardi, Davide
    LARYNGOSCOPE, 2021, 131 (03) : E1029 - E1034
  • [23] Associations Between Sex-Specific Reproductive Factors and Risk of New-Onset Lung Cancer Among Female Patients
    Zhang, Yan
    Liang, Huaying
    Cheng, Jun
    Choudhry, Abira A.
    Zhou, Xin
    Zhou, Guowei
    Zhu, Yiqun
    Li, Dianwu
    Lin, Fengyu
    Chang, Qinyu
    Jing, Danrong
    Chen, Xiang
    Pan, Pinhua
    Liu, Hong
    CHEST, 2024, 166 (01) : 226 - 239
  • [24] The regulation of proliferation and invasion in differentiated thyroid cancer by growth factors
    Hoelting, T
    Duh, QY
    Clark, OH
    Herfarth, C
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1996, 104 : 29 - 31
  • [25] Differentiated thyroid cancer in children: Heterogeneity of predictive risk factors
    Russo, Marco
    Malandrino, Pasqualino
    Moleti, Mariacarla
    Vermiglio, Francesco
    D'Angelo, Antonio
    La Rosa, Giuliana
    Sapuppo, Giulia
    Calaciura, Francesca
    Regalbuto, Concetto
    Belfiore, Antonino
    Vigneri, Riccardo
    Pellegriti, Gabriella
    PEDIATRIC BLOOD & CANCER, 2018, 65 (09)
  • [26] Prognostic factors for recurrence of locally advanced differentiated thyroid cancer
    Kim, Bo-Young
    Choi, Ji-Eun
    Lee, Eunkyu
    Son, Young-Ik
    Baek, Chung-Hwan
    Kim, Sun Woo
    Chung, Man Ki
    JOURNAL OF SURGICAL ONCOLOGY, 2017, 116 (07) : 877 - 883
  • [27] The Role of Genetic Polymorphisms in Differentiated Thyroid Cancer: A 2023 Update
    Tiuca, Robert Aurelian
    Tiuca, Oana Mirela
    Pascanu, Ionela Maria
    BIOMEDICINES, 2023, 11 (04)
  • [28] Bone mineral density in treated at a young age for differentiated thyroid cancer after Chernobyl female patients on TSH-suppressive therapy receiving or not Calcium-D3 supplementation
    Leonova, Tatiana A.
    Drozd, Valentina M.
    Saenko, Vladimir A.
    Mine, Mariko
    Biko, Johannes
    Rogounovitch, Tatiana I.
    Takamura, Noboru
    Reiners, Christoph
    Yamashita, Shunichi
    ENDOCRINE JOURNAL, 2015, 62 (02) : 173 - 182
  • [29] Risk Factors for Indeterminate Response After Radioactive Iodine Therapy in Patients With Differentiated Thyroid Cancer
    Jeong, Eugene
    Yoon, Joon-Kee
    Lee, Su Jin
    Soh, Euy Young
    Lee, Jeonghun
    An, Young-Sil
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (09) : 714 - 718
  • [30] EVALUATION OF PROGNOSIS AND RISK FACTORS OF DIFFERENTIATED THYROID CANCER IN A GERIATRIC POPULATION
    Altay, Feride Pinar
    Cicek, Ozgon
    Demirkan, Ecem
    Taskaldiran, Isilay
    Bozkus, Yusuf
    Iyidir, Ozlem Turhan
    Nar, Asli
    Tutuncu, Neslihan Bascil
    TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI, 2023, 26 (02): : 118 - 123